Earlier today I reported the news that Victor Dzau, the chancellor for health affairs at Duke University and the CEO of the Duke University Health System, would become the next president of the Institute of Medicine. But I failed to remember that I had written about Dzau several years ago. I think it will be of interest to…
Newly Elected President Of Institute of Medicine Is On The Pepsico Board Of Directors
February 19, 2014 by 4 Comments
FDA Advisory Panel Backs Looser Restrictions On Avandia
June 6, 2013 by Leave a Comment
After two days of deliberation an FDA advisory panel today recommended that the severe restrictions (REMS) placed on rosiglitazone (Avandia, GlaxoSmithKline) be modified. The vote constitutes a modest revival in fortune for the embattled drug and its maker after many years of controversy and bad news. Only 5 panel members voted to continue the current severe restrictions….
Recent Comments